Case Report
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Jan 16, 2023; 11(2): 441-448
Published online Jan 16, 2023. doi: 10.12998/wjcc.v11.i2.441
Gefitinib improves severe bronchorrhea and prolongs the survival of a patient with lung invasive mucinous adenocarcinoma: A case report
Guo-Chun Ou, Wen Luo, Wei-Shan Zhang, Shu-Hong Wang, Jie Zhao, Hong-Mei Zhao, Rong Qiu
Guo-Chun Ou, Wen Luo, Shu-Hong Wang, Jie Zhao, Hong-Mei Zhao, Rong Qiu, Department of Respiratory and Critical Care Medicine, Suining Central Hospital, Suining 629000, Sichuan Province, China
Wei-Shan Zhang, Department of Pathology, Suining Central Hospital, Suining 629000, Sichuan Province, China
Author contributions: All authors have read and approved the manuscript, and significantly contributed to this paper. Ou GC, Luo W, Zhang WS, Wang SH, Zhao J, Zhao HM, and Qiu R contributed to conception and design, literature review, manuscript writing and correction, final approval of manuscript; Ou GC and Luo W contributed equally to this work; All authors read and approved the final manuscript.
Supported by the Science and Technology Research Project of Sichuan Provincial Administration of Traditional Chinese Medicine, No. 2021MS164; Scientific research project of Sichuan Medical Association, No. S21012.
Informed consent statement: Written informed consent to publish this information was obtained from the patient.
Conflict-of-interest statement: All the authors declare that they have no competing interests.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Rong Qiu, PhD, Doctor, Department of Respiratory and Critical Care Medicine, Suining Central Hospital, No. 27 Dongping North Road, Hedong New District, Chuanshan District, Suining 629000, Sichuan Province, China. snszxyyqr@126.com
Received: October 9, 2022
Peer-review started: October 9, 2022
First decision: December 13, 2022
Revised: December 21, 2022
Accepted: January 3, 2023
Article in press: January 3, 2023
Published online: January 16, 2023
Processing time: 94 Days and 21.6 Hours
Core Tip

Core Tip: Gefitinib improves severe bronchorrhea and prolongs the survival of a patient with lung invasive mucinous adenocarcinoma.